| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |